Riveron is a private equity owned national business advisory firm of 1,200+ people specializing in Accounting, ESG, Finance, M&A, Operations, Restructuring, Strategic Communications, Tax, and Technology. With a broad range of functional and industry expertise, we partner with private equity firms, the office of the CFO, and lenders to implement solutions across the transaction and business lifecycle.♦ Responsible for practice development and client service that advances the Business Performance practice, specializing in financial planning and analysis and technology offerings including CPM/OneStream.♦ Serve in pivotal executive roles encompassing a high level of responsibility and financial advisory, focusing on Financial Planning & Analysis (FP&A), financial technology, and strategic client solutions. Transitioned successfully from corporate roles to consulting advisory and business development. Balance roles as a consultant/project leader and serving as interim Chief Financial Officer (CFO), adapting to diverse client needs. Majority of assignments serve private equity owned clients.

Fresh Vine Wine, Inc. (NYSE American: VINE), the premier producer premium wines. ♦ Direct report and right hand to CEO in executing strategic and operational plans to create brand awareness and drive distribution♦ Joined a dynamic organization immediately following the company’s IPO, tasked with revitalizing financial and operational strategies. Assessed and corrected issues with cash flow and financial controls, addressing discrepancies between projected and actual expenditures. Navigated the company through a critical period, implementing measures to extend operational viability.

Publicly Traded Global Contract Medical Device Manufacturer (NASDAQ: IIN)~$125M Annual Revenues.Honored for work by the Twin Cities Business Magazine: Notable Woman in Manufacturing, 2021 and the Mpls St Paul Business Journal: CFO of Year Nominee, 2021♦ Reported directly to the Chief Executive Officer, tasked with driving operational excellence and strategic growth. Oversaw all financial operations and systems and legal team. Restructured global Finance & Accounting teams spanning manufacturing plants across U.S., Asia, and Europe, ensuring alignment and efficiency. Managed 8 direct reports and a team of 30 high-performing professionals♦ Provided Board of Directors a transformative view of financial operations and systemic challenges, guiding decision to pursue privatization to secure a strategic path forward for the company.

Publicly Traded Global Manufacturer and Retailer of Life Science and Diagnostics Products (NASDAQ: TECH), ~ $1.1B in Annual Revenues. During tenure, the company grew organically and via 16 acquisitions. Total M&A spend of ~$1.8B resulting in ownership post integration and consolidation of 15 varied manufacturing facilities, 6 key distribution facilities, and 12 commercial sales offices across the USA, Europe, and ASIA.Joined during a significant transformation as company tripled in revenue organically and via acquisitions while growing market capitalization 6x and maintaining strong profitability. This resulted in a complex global organization of 6 Divisions comprised of 15 varied manufacturing facilities, 6 key distribution facilities, and 12 commercial sales offices (across USA, Europe, and ASIA) With company growth and personal promotions, role and responsibilities grew. Throughout tenure, served as direct report, right hand and chief of staff to CFO, and trusted business partner to the entire C-suite, matrixed Global Leadership Team, Controllership, Auditors, and the Board of Directors. Over 6 year tenure built direct world class Finance staff from 1 to 35 while also leading Regional Finance and Accounting staff for Europe and Asia of 20. As chief of staff to CFO indirectly managed global Finance and Accounting staff which grew from 20 ~ 85 worldwide. Throughout tenure delivered M&A financial and risk due diligence and valuation modeling for numerous potential deals as well as post-acquisition integration of all financial processes and systems for 16 acquisitions. ♦ Led Strategy, Financial Planning and Analysis, Financial Close, and Financial Systems for ~$1.1B Enterprise, $250M Business Segment, and $110M (expense) Corporate Division. Served as key business partner to Executive Team, Segment EVP and 3 Divisional GMs, and 11 Corporate Functional Leaders

Led Strategic Planning, Global Financial Operations, Financial Planning and Analysis, Management Reporting, and Corporate Finance while retaining all responsibilities of prior role♦ Led Enterprise Strategic Planning activities to define comprehensive 5-year playbook across Global Executive Leadership Team of 18 matrixed divisional, regional, and functional leaders. Annual 3-month project to define, model and prioritize 300+ cost benefit analyses that set and delivered company short and long term performance expectations

Established first ever Financial Planning and Analysis function to lead enterprise financial operations and manage financial systems. Led enterprise close/consolidation, quarterly forecasting, financial reporting, foreign exchange analysis, cash forecasting, and annual planning/budgeting♦ Selected, developed, and implemented Hyperion Financial Management (HFM) system to automate worldwide accounting month-end close and consolidation across 23 ERP systems and 22 currencies. Reduced enterprise financial close process by 5 business days

Cenex Harvest States, Fortune100 Agriculture & Energy CooperativeKey business partner to Executive Leadership Team and Board of Directors. Established company's Strategy Office as well as company's Financial Planning and Analysis function